Sinovac Investor Settles SEC Disclosure Claims For $290K
An activist investor and his firm have agreed to pay $290,000 to settle U.S. Securities and Exchange Commission claims that they failed to disclose their increasing stake in Sinovac Biotech as...To view the full article, register now.
Already a subscriber? Click here to view full article